Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.

Ohlsson S, Holm L, Hansson C, Ohlsson SM, Gunnarsson L, Pettersson Å, Skattum L.

PLoS One. 2019 Jun 19;14(6):e0218272. doi: 10.1371/journal.pone.0218272. eCollection 2019.

2.

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis.

Hellmark T, Ohlsson S, Pettersson Å, Hansson M, Johansson ÅCM.

BMC Rheumatol. 2019 Mar 8;3:9. doi: 10.1186/s41927-019-0059-6. eCollection 2019.

3.

Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis.

Lilliebladh S, Johansson Å, Pettersson Å, Ohlsson S, Hellmark T.

J Immunol Res. 2018 Oct 30;2018:6984563. doi: 10.1155/2018/6984563. eCollection 2018.

4.

Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.

Ohlsson S, Diedrich B, Uhlin M, Sandgren P.

Vox Sang. 2018 Oct;113(7):611-621. doi: 10.1111/vox.12696. Epub 2018 Aug 29.

PMID:
30156292
5.

Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene.

Jönsson N, Erlandsson E, Gunnarsson L, Pettersson Å, Ohlsson S.

Mediators Inflamm. 2018 Mar 12;2018:6861257. doi: 10.1155/2018/6861257. eCollection 2018.

6.

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

McAdoo SP, Tanna A, Hrušková Z, Holm L, Weiner M, Arulkumaran N, Kang A, Satrapová V, Levy J, Ohlsson S, Tesar V, Segelmark M, Pusey CD.

Kidney Int. 2017 Sep;92(3):693-702. doi: 10.1016/j.kint.2017.03.014. Epub 2017 May 12.

7.

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

Alberici F, Smith RM, Fonseca M, Willcocks LC, Jones RB, Holle JU, Wieczorek S, Neumann T, Martorana D, Gregorini G, Sinico RA, Bruchfeld A, Gunnarsson I, Ohlsson S, Baslund B, Tesar V, Hruskova Z, Cid MC, Vaglio A, Lyons PA, Smith KGC, Jayne DRW.

J Allergy Clin Immunol. 2017 May;139(5):1684-1687.e10. doi: 10.1016/j.jaci.2016.08.051. Epub 2016 Oct 22. No abstract available.

PMID:
27780742
8.

Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis.

Landegren N, Pourmousa Lindberg M, Skov J, Hallgren Å, Eriksson D, Lisberg Toft-Bertelsen T, MacAulay N, Hagforsen E, Räisänen-Sokolowski A, Saha H, Nilsson T, Nordmark G, Ohlsson S, Gustafsson J, Husebye ES, Larsson E, Anderson MS, Perheentupa J, Rorsman F, Fenton RA, Kämpe O.

J Am Soc Nephrol. 2016 Oct;27(10):3220-3228. Epub 2016 Mar 16.

9.

ISPyB for BioSAXS, the gateway to user autonomy in solution scattering experiments.

De Maria Antolinos A, Pernot P, Brennich ME, Kieffer J, Bowler MW, Delageniere S, Ohlsson S, Malbet Monaco S, Ashton A, Franke D, Svergun D, McSweeney S, Gordon E, Round A.

Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):76-85. doi: 10.1107/S1399004714019609. Epub 2015 Jan 1.

10.

Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.

Johansson ÅC, Ohlsson S, Pettersson Å, Bengtsson AA, Selga D, Hansson M, Hellmark T.

Arthritis Res Ther. 2016 Apr 22;18:92. doi: 10.1186/s13075-016-0994-1.

11.

In Reply to 'IgG4-Restricted Anti-Glomerular Basement Membrane Autoantibodies Targeting Quaternary Epitopes of Native α345(IV) Collagen'.

Ohlsson S, Segelmark M.

Am J Kidney Dis. 2014 Jul;64(1):157. doi: 10.1053/j.ajkd.2014.04.023. No abstract available.

12.

Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, Andersson AC, Lindstedt P, Stenvang J, Gullberg M, Fredriksson S.

PLoS One. 2014 Apr 22;9(4):e95192. doi: 10.1371/journal.pone.0095192. eCollection 2014.

13.

Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies.

Ohlsson SM, Ohlsson S, Söderberg D, Gunnarsson L, Pettersson Å, Segelmark M, Hellmark T.

Clin Exp Immunol. 2014 Jun;176(3):363-72. doi: 10.1111/cei.12301.

14.

Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.

Ohlsson SM, Linge CP, Gullstrand B, Lood C, Johansson A, Ohlsson S, Lundqvist A, Bengtsson AA, Carlsson F, Hellmark T.

Clin Immunol. 2014 May-Jun;152(1-2):10-9. doi: 10.1016/j.clim.2014.02.016. Epub 2014 Mar 12.

PMID:
24631966
15.

Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.

Tofik R, Ohlsson S, Bakoush O.

PLoS One. 2014 Jan 29;9(1):e87857. doi: 10.1371/journal.pone.0087857. eCollection 2014.

16.

Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.

Ohlsson S, Herlitz H, Lundberg S, Selga D, Mölne J, Wieslander J, Segelmark M.

Am J Kidney Dis. 2014 Feb;63(2):289-93. doi: 10.1053/j.ajkd.2013.08.032. Epub 2013 Nov 1.

PMID:
24189476
17.

Upgraded ESRF BM29 beamline for SAXS on macromolecules in solution.

Pernot P, Round A, Barrett R, De Maria Antolinos A, Gobbo A, Gordon E, Huet J, Kieffer J, Lentini M, Mattenet M, Morawe C, Mueller-Dieckmann C, Ohlsson S, Schmid W, Surr J, Theveneau P, Zerrad L, McSweeney S.

J Synchrotron Radiat. 2013 Jul;20(Pt 4):660-4. doi: 10.1107/S0909049513010431. Epub 2013 May 18.

18.

Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

Ohlsson SM, Pettersson Å, Ohlsson S, Selga D, Bengtsson AA, Segelmark M, Hellmark T.

Clin Exp Immunol. 2012 Oct;170(1):47-56. doi: 10.1111/j.1365-2249.2012.04633.x.

19.

Genetically distinct subsets within ANCA-associated vasculitis.

Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG.

N Engl J Med. 2012 Jul 19;367(3):214-23. doi: 10.1056/NEJMoa1108735.

20.

Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP.

Rørvig S, Honore C, Larsson LI, Ohlsson S, Pedersen CC, Jacobsen LC, Cowland JB, Garred P, Borregaard N.

J Leukoc Biol. 2009 Dec;86(6):1439-49. doi: 10.1189/jlb.1008606. Epub 2009 Sep 9.

PMID:
19741154
21.

Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.

Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M.

Mediators Inflamm. 2009;2009:584916. doi: 10.1155/2009/584916. Epub 2009 Jul 5.

22.

How practice produces suboptimal heuristics that render backup instruments ineffective.

Youmans RJ, Ohlsson S.

Ergonomics. 2008 Apr;51(4):441-75. doi: 10.1080/00140130701685659.

PMID:
18357535
23.

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers.

Baldwin RM, Ohlsson S, Pedersen RS, Mwinyi J, Ingelman-Sundberg M, Eliasson E, Bertilsson L.

Br J Clin Pharmacol. 2008 May;65(5):767-74. doi: 10.1111/j.1365-2125.2008.03104.x. Epub 2008 Feb 20.

24.

Psychology is about processes.

Ohlsson S.

Integr Psychol Behav Sci. 2007 Mar;41(1):28-34; discussion 75-82.

PMID:
17992866
25.

Noscapine may increase the effect of warfarin.

Ohlsson S, Holm L, Myrberg O, Sundström A, Yue QY.

Br J Clin Pharmacol. 2008 Feb;65(2):277-8. Epub 2007 Sep 13. Review. No abstract available.

26.

Geochemical anomalies from bottom ash in a road construction--comparison of the leaching potential between an ash road and the surroundings.

Lind BB, Norrman J, Larsson LB, Ohlsson SA, Bristav H.

Waste Manag. 2008;28(1):170-80. Epub 2007 Feb 15.

PMID:
17306524
27.

Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3-year results of the START study.

Tan WC, Lamm CJ, Chen YZ, O'Byrne PM, Pedersen S, Busse WW, Ohlsson SV, Ullman A, Andersson B, Pauwels RA.

Respirology. 2006 Nov;11(6):767-75.

PMID:
17052306
28.

[Triptans and stroke].

Ohlsson S, Helldén A.

Lakartidningen. 2006 Jul 26-Aug 8;103(30-31):2236. Swedish. No abstract available.

PMID:
16921979
29.

NIKE: a new clinical tool for establishing levels of indications for cataract surgery.

Lundström M, Albrecht S, Håkansson I, Lorefors R, Ohlsson S, Polland W, Schmid A, Svensson G, Wendel E.

Acta Ophthalmol Scand. 2006 Aug;84(4):495-501.

30.

Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma.

O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA; START Investigators Group.

Chest. 2006 Jun;129(6):1478-85.

PMID:
16778264
31.

[Waran following thrombolysis with Actilyse].

Ohlsson S, Böttiger Y.

Lakartidningen. 2006 Mar 15-21;103(11):853. Swedish. No abstract available.

PMID:
16613115
32.

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.

Lundblad MS, Ohlsson S, Johansson P, Lafolie P, Eliasson E.

Clin Pharmacol Ther. 2006 Mar;79(3):287-8. No abstract available.

PMID:
16513453
33.

Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.

Bakoush O, Segelmark M, Torffvit O, Ohlsson S, Tencer J.

Nephrol Dial Transplant. 2006 May;21(5):1263-9. Epub 2006 Jan 31.

PMID:
16449276
34.

Comparing Multiple Paths to Mastery: What is Learned?

Nokes TJ, Ohlsson S.

Cogn Sci. 2005 Sep 10;29(5):769-96. doi: 10.1207/s15516709cog0000_32.

35.

Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.

Ohlsson S, Hellmark T, Pieters K, Sturfelt G, Wieslander J, Segelmark M.

Clin Exp Immunol. 2005 Jul;141(1):174-82.

36.
37.

Multiple causes of difficulty in insight: the case of the nine-dot problem.

Kershaw TC, Ohlsson S.

J Exp Psychol Learn Mem Cogn. 2004 Jan;30(1):3-13.

PMID:
14736292
38.

Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.

Hellmark T, Chen L, Ohlsson S, Wieslander J, Bolton WK.

J Biol Chem. 2003 Nov 21;278(47):46516-22. Epub 2003 Sep 11.

39.

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.

Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O'Byrne PM; START Investigators Group.

Lancet. 2003 Mar 29;361(9363):1071-6.

PMID:
12672309
41.

Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.

Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J.

Clin Exp Immunol. 2003 Jan;131(1):190-6.

42.

Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.

Johnell O, Pauwels R, Löfdahl CG, Laitinen LA, Postma DS, Pride NB, Ohlsson SV.

Eur Respir J. 2002 Jun;19(6):1058-63.

43.

An eye movement study of insight problem solving.

Knoblich G, Ohlsson S, Raney GE.

Mem Cognit. 2001 Oct;29(7):1000-9.

PMID:
11820744
44.

Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.

Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J.

Mediators Inflamm. 2001 Dec;10(6):347-50.

45.

The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design.

Pauwels RA, Busse WW, O'Byrne PM, Pedersen S, Tan WC, Chen YZ, Ohlsson SV, Ullman A.

Control Clin Trials. 2001 Aug;22(4):405-19.

PMID:
11514041
46.

Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.

Graffner-Nordberg M, Marelius J, Ohlsson S, Persson A, Swedberg G, Andersson P, Andersson SE, Aqvist J, Hallberg A.

J Med Chem. 2000 Oct 19;43(21):3852-61.

PMID:
11052790
47.
48.

The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies.

Löfdahl CG, Postma DS, Laitinen LA, Ohlsson SV, Pauwels RA, Pride NB.

Respir Med. 1998 Mar;92(3):467-72.

49.

Persistent B19 parvovirus infection in pediatric malignancies.

Broliden K, Tolfvenstam T, Ohlsson S, Henter JI.

Med Pediatr Oncol. 1998 Aug;31(2):66-72.

PMID:
9680929
50.

Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage.

Ohlsson S, Tufvesson B, Polling A, Ohlsson K.

Biol Chem. 1997 Sep;378(9):1055-8.

PMID:
9348116

Supplemental Content

Loading ...
Support Center